Navigation Links
How do data exclusivity periods affect pharmaceutical innovation?
Date:1/6/2011

LOS ANGELES, Calif. January 6, 2011 Pharmaceutical companies and generic drug manufacturers have long been at odds over regulations about "data exclusivity," the period of time before generic manufacturers can make use of valuable clinical trial data.

A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.

"Elected officials are unlikely to embrace legislation that would result in higher drug prices, but our research suggests that legislation to extend data exclusivity would spur innovation that would benefit future generations," explained Dana Goldman, lead author, director of the Schaeffer Center for Health Policy and Economics at USC and Norman Topping Chair in Medicine and Public Policy at USC.

The pharmaceutical companies that introduce new drugs are currently granted five years of exclusive access to the clinical trial data they submit during the approval process. An extension of three years is available if new applications arise and a six month extension is granted if the drug is approved for use in pediatric populations.

In 2007, the National Academies Committee on Science, Engineering and Public Policy called for extending this "data exclusivity" term to the longer period used in Europe, ten to 11 years. But generic manufacturers have argued for shorter limits so that they can bring less expensive versions of drugs to patients sooner.

"Unfortunately, the health policy literature contains no information about the effects such a policy would have on innovation, population longevity and social welfare," said Darius Lakdawalla, research director at the Schaeffer Center at USC and associate professor in th
'/>"/>

Contact: Suzanne Wu
suzanne.wu@usc.edu
213-740-0252
University of Southern California
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene Activity May Affect Acute Myeloid Leukemia Outcome
2. Vitamin D and parathyroid hormone levels may not affect cardiovascular mortality
3. Depression During Pregnancy Might Affect Baby
4. How MS Affects Kids May Differ by Race
5. Marital Status May Affect Kidney Transplant Decision
6. Research Finds Not All HIV Affects Immune System Same Way
7. Working With Pesticides May Affect Memory and More
8. Sleepless soldiers: Study suggests that military deployment affects sleep patterns
9. Trust in Doctor May Affect Reaction to Medical Error
10. Too Much Hygiene May Affect Immune System, Study Suggests
11. Social Class May Affect Outcome of Depression Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... Energy Devices Market 2006 to 2020 - Asia-Pacific” ... and energy devices market segments: minimally invasive body ... resurfacing devices. The analysis includes market size data ... period for the following countries: China, Japan, South ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot ... be providing an 8 year warranty on its selected hot ... went up due to the impending winter season, it was ... the premium service that the company provides. As a result, ... John Wood and Bradford hot water tanks. , “Every ...
(Date:11/23/2014)... -- Close friends have more influence on teens, alcohol ... study says. "We,ve known for a long ... individual alcohol use, but there are no common studies ... friend group,s influence on those decisions," Jonathon Beckmeyer, an ... said in a university news release. Beckmeyer analyzed ...
(Date:11/23/2014)... November 23, 2014 Locks-Magnetic.com, a notable ... doors. Moreover, all the new products are available at ... marketing manager is proud of the new emergency doors. ... automatically. And customers can choose from several colors. All ... high quality emergency door release is not as easy ...
(Date:11/23/2014)... To show thanks to new and old ... white evening dresses for weddings. Customers who need ... iFitDress.com is a distinguished dress manufacturer, and it is among ... customers for a very long time. The CEO of this ... will be able to buy not only a beautiful dress, ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... patients is in early period , , TUESDAY, Feb. 5 (HealthDay ... after heart patients stop taking the clot-preventing drug Plavix are ... make this observation," said Dr. P. Michael Ho, a cardiologist ... a report in the Feb. 6 issue of the ...
... ,PLAY SAFE IN THE SUN, ... ... a,subsidiary of the L,Oreal Group, announced that they have granted the,Women,s Dermatologic ... Safe in the Sun campaign, effective April,2008. The WDS educational outreach campaign ...
... William F. Balistreri, MD, Editor of The Journal of ... the Study of Liver Diseases (AASLD) 2007 Distinguished Service ... AASLD as well as to the liver disease community. ... award. , The AASLD was privileged to honor Dr. ...
... of the sardine fishery off California for decades has ... large fluctuations in the sardine population. Before its collapse, ... and formed the setting of John Steinbecks Cannery Row ... Oceanography at UC San Diego have now shed light ...
... Magazine,s list ranks 33, COLUMBUS, Ga., Feb. ... education and leadership programs helped Aflac leap to,Number ... for,employees according to Training Magazine,s annual Top 125 ... Georgia World Congress Center, the,insurer was honored for ...
... NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an ... and treatment of the disease. The new Cancer ... Andrew Dannenberg. , A joint initiative of Weill ... will create strengthened and expanded research programs and ...
Cached Medicine News:Health News:First 90 Days After Stopping Plavix Most Dangerous 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 2Health News:L'Oreal USA Announces Three-Year Support of Women's Dermatologic Society Foundation Community Outreach 3Health News:William F. Balistreri, M.D., honored with Distinguished Service Award by AASLD 2Health News:Scripps scientists peg wind as the force behind fish booms and busts 2Health News:Scripps scientists peg wind as the force behind fish booms and busts 3Health News:Training Magazine Applauds Aflac's Employee Learning Programs 2Health News:Training Magazine Applauds Aflac's Employee Learning Programs 3Health News:NewYork-Presbyterian/Weill Cornell creates world-class cancer center 2
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced ... will be presenting at the 26 th Annual Piper ... New York . The formal presentation is ... In addition, Mr. Krakauer and Jorgen B. Hansen , ... during the day. An audio webcast will ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... BioTrends Research Group, Inc. announces the release of the ... and Cimzia report. The survey was completed by ... qualitative interviews with a subset (n=20) of the survey respondents to ... employed to differentiate the products. Over the course of the ...
... , ATLANTA, Dec. 23 Alimera Sciences, Inc., a privately ... commercialization of prescription ophthalmic pharmaceuticals, today reported top-line results from ... The FAME Study consists of two Phase 3 pivotal clinical ... Iluvien in the treatment of diabetic macular edema (DME). The ...
Cached Medicine Technology:Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 2Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey 3Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 2Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 3Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 4Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 5Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: